Advanced Primary Peritoneal Carcinoma
Drug | Drug Name | Drug Description |
---|---|---|
DB11793 | Niraparib | A poly-ADP ribose polymerase inhibitor used to treat recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer responding to platinum based chemotherapy. |
DB09074 | Olaparib | A poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11740 | Adavosertib | 0 | Active Not Recruiting | 1 |
DB18028 | Azenosertib | 0 | Withdrawn | 1 |
DB00062 | Albumin human | 1 | Recruiting | 1 |
DB11595 | Atezolizumab | 1 | Recruiting | 1 |
DB08875 | Cabozantinib | 1 | Recruiting | 1 |
DB00441 | Gemcitabine | 1 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 1 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Active Not Recruiting | 1 |
DB01262 | Decitabine | 1 / 2 | Active Not Recruiting | 1 |
DB17107 | Lifileucel | 1 / 2 | Active Not Recruiting | 1 |